Search Results - "Peters, Cole"
-
1
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
Published in Clinical cancer research (15-07-2018)“…Glioblastoma (GBM), a fatal brain cancer, contains a subpopulation of GBM stem-like cells (GSCs) that contribute to resistance to current therapy. Angiogenesis…”
Get full text
Journal Article -
2
Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules
Published in International journal of molecular sciences (22-08-2021)“…The dogma of engineering oncolytic viral vectors has shifted from emphasizing the viral lysis of individual cancer cells to the recruitment and coordination of…”
Get full text
Journal Article -
3
Delivering AAV to the Central Nervous and Sensory Systems
Published in Trends in pharmacological sciences (Regular ed.) (01-06-2021)“…As gene therapy enters mainstream medicine, it is more important than ever to have a grasp of exactly how to leverage it for maximum benefit. The development…”
Get full text
Journal Article -
4
Mini-PCDH15 gene therapy rescues hearing in a mouse model of Usher syndrome type 1F
Published in Nature communications (26-04-2023)“…Usher syndrome type 1 F (USH1F), caused by mutations in the protocadherin-15 gene ( PCDH15 ), is characterized by congenital deafness, lack of balance, and…”
Get full text
Journal Article -
5
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F
Published in Molecular therapy (02-08-2023)“…Usher syndrome type 1F (USH1F), characterized by congenital lack of hearing and balance and progressive loss of vision, is caused by mutations in the PCDH15…”
Get full text
Journal Article -
6
Designing herpes viruses as oncolytics
Published in Molecular therapy. Oncolytics (2015)“…Oncolytic herpes simplex virus (oHSV) was one of the first genetically-engineered oncolytic viruses. Because HSV is a natural human pathogen that can cause…”
Get full text
Journal Article -
7
Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non‐human primate
Published in American journal of transplantation (01-03-2022)“…Clinical islet transplantation has relied almost exclusively on intraportal administration of pancreatic islets, as it has been the only consistent approach to…”
Get full text
Journal Article -
8
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
Published in Molecular therapy. Methods & clinical development (11-06-2021)“…Gene therapy strategies using adeno-associated virus (AAV) vectors to treat hereditary deafnesses have shown remarkable efficacy in some mouse models of…”
Get full text
Journal Article -
9
Updates on Oncolytic Virus Immunotherapy for Cancers
Published in Molecular therapy. Oncolytics (29-03-2019)“…The 2018 annual Cambridge Healthtech Institute’s International Immuno-Oncology Summit in Boston, MA convened late August, and academic and industry researchers…”
Get full text
Journal Article -
10
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy
Published in Cancer immunology research (02-12-2022)“…A major complication of chimeric antigen receptor (CAR) T-cell therapy is immune effector cell-associated neurotoxicity syndrome (ICANS), which presents as…”
Get more information
Journal Article -
11
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy
Published in Cancer immunology research (01-12-2023)“…Transgenic T-cell receptor (TCR) T cell-based adoptive cell therapies for solid tumors are associated with dramatic initial response rates, but there remain…”
Get more information
Journal Article -
12
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade
Published in Journal for immunotherapy of cancer (01-05-2023)“…BackgroundThe tumor antigen NY-ESO-1 has been shown to be an effective target for transgenic adoptive cell therapy (ACT) for the treatment of sarcoma and…”
Get full text
Journal Article -
13
FasL microgels induce immune acceptance of islet allografts in nonhuman primates
Published in Science advances (13-05-2022)“…Islet transplantation to treat insulin-dependent diabetes is greatly limited by the need for maintenance immunosuppression. We report a strategy through which…”
Get full text
Journal Article -
14
Construction of a Sonchus Yellow Net Virus Minireplicon: a Step toward Reverse Genetic Analysis of Plant Negative-Strand RNA Viruses
Published in Journal of Virology (01-10-2013)“…Erratum ( vol. 87 , p. 13081 ) Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious…”
Get full text
Journal Article -
15
PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1F Models
Published in The Journal of clinical investigation (15-10-2024)“…Usher syndrome type 1F (USH1F), resulting from mutations in the protocadherin-15 (PCDH15) gene, is characterized by congenital lack of hearing and balance, and…”
Get full text
Journal Article -
16
Oncolytic Herpes Simplex Viruses as a Paradigm for the Treatment of Cancer
Published in Annual review of cancer biology (04-03-2018)“…Oncolytic viruses are native or modified viruses that directly kill tumor cells but spare normal tissue and promote host antitumor immunity. Recently, an…”
Get full text
Journal Article -
17
Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates
Published in Cell reports. Medicine (21-03-2023)“…The transplanting islets to the liver approach suffers from an immediate posttransplant loss of islets of more than 50%, progressive graft dysfunction over…”
Get full text
Journal Article -
18
Oncolytic viruses on the cusp of success?: proceedings of the 9th International Conference on Oncolytic Virus Therapeutics
Published in Molecular therapy. Oncolytics (08-06-2016)“…Boston, Massachusetts, was the site of the 9th International Conference on Oncolytic Virus Therapeutics held 13–16 June 2015. An overarching theme of the…”
Get full text
Journal Article -
19
Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
Published in JNCI : Journal of the National Cancer Institute (01-03-2017)“…Clinical success of poly(ADP-ribose) polymerase inhibitors (PARP i ) has been limited to repair-deficient cancers and by resistance. Oncolytic herpes simplex…”
Get full text
Journal Article -
20